Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

CompletedOBSERVATIONAL
Enrollment

409

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 26, 2023

Study Completion Date

April 2, 2023

Conditions
Migraine
Interventions
DEVICE

Nerivio

Remote electrical neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application

Trial Locations (2)

08807

Theranica USA Inc, Bridgewater

Unknown

Theranica Bio-Electronics Ltd, Netanya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT05760638 - Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN) | Biotech Hunter | Biotech Hunter